Home | About | Contacts| News | Quick Links | Search

 
         

 

For Patients For Providers Academics Careers Services Locations How to Give  

 

About Us

News Home

Press Releases

Research

Experts

Awards

Archives

Join Our Media mailing list

Media Opportunity Consent Form

 
 
 

 

NEWS FROM CAMBRIDGE HEALTH ALLIANCE

July 8, 2009

Cambridge Health Alliance Offers Innovative Treatment for Opioid Addiction

Cambridge, Chelsea, Everett, Malden, Medford, Revere, Somerville, MA...Are you concerned about a loved one's or your own opioid drug use? Summer represents a time of outdoor activities. Yet, for many individuals and their families, addiction prevents them from enjoying these activities. The Opioid Addiction and Family Project may be able to help.

The Opioid Addiction and Family Project is a program designed to help adults addicted to opioids, chemical substances commonly used for pain relief, such as heroin or oxycodone. The Project is a study conducted by researchers at Cambridge Health Alliance (CHA) and Harvard Medical School to examine if adding family counseling to individual counseling and recovery medication improves treatment outcomes.

"We are very pleased to be able to offer this innovative treatment option to people suffering from opioid addiction," said Mark Albanese, MD, CHA's Director of Addiction Services. "We are making inroads in a number of communities plagued by opioid abuse and have been able to help many people stop excessive drug use and get their lives back on track."

Adults seeking help for an opioid addiction may be eligible for the program if they are between 21 and 65 years old and live with a family member. That family member may be a spouse, intimate partner, parent, grandparent, sibling, or adult child. All participants will receive free individual counseling, and half of all participants will also receive free family counseling. The counseling will consist of 32 sessions total over the course of 4-5 months.

Additionally, all participants will receive free Naltrexone medication. Naltrexone is an opiate blocker approved by the Food and Drug Administration for the treatment of opioid dependence which has been shown to improve treatment outcomes. Treatment and counseling sessions will take place at CHA's Central Street Health Center in Somerville, Mass.

For more information, please visit www.cha.harvard.edu/opioid or call the Opioid Addiction and Family Project at Cambridge Health Alliance at (617) 591-6055.

Cambridge Health Alliance is an innovative, award-winning health system that provides high quality care in Cambridge, Somerville, and Boston's metro-north communities. It includes three hospital campuses, a network of primary care and specialty practices, the Cambridge Public Health Dept., and the Network Health plan. CHA is a Harvard Medical School teaching affiliate and is also affiliated with Harvard School of Public Health, Harvard School of Dental Medicine, and Tufts University School of Medicine. Visit us online at www.challiance.org.

 


 

 

Media Contact

David Cecere
Media Relations Manager
Phone: 617-503-8428
Cell: 617-921-9613
Pager: 617-546-1879
dcecere@challiance.org